Publicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (10)

2024

  1. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  2. Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study

    European Journal of Neurology, Vol. 31, Núm. 5

  3. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study

    Frontiers in Neurology , Vol. 15

  4. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

  5. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world

    Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937

2022

  1. Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study

    European Journal of Neurology, Vol. 29, Núm. 10, pp. 3102-3111

2021

  1. 1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress

    Revista de Neurologia

  2. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry

    Journal of the Neurological Sciences, Vol. 423

2019

  1. Neurocooperación: Un nuevo horizonte de la neurología

    Kranion, Vol. 14, Núm. 3, pp. 114-119

  2. Neurología y cooperación: ¿Utopía o realidad? Experiencia de un proyecto pionero de neurocooperación en África

    Kranion, Vol. 14, Núm. 2, pp. 67-72